AptarGroup
ATR • NYSE
AptarGroup is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Stephan Tanda, with a market cap of $7.8B.
CEOStephan Tanda
Next Earnings
Upcoming earnings announcement for AptarGroup
Date
Thursday, April 30, 2026 (in 3 weeks)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.16
Revenue Estimate
$958.9M
Earnings History
Past 12 earnings reports for AptarGroup
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q4 2025 | $1.25Est: $1.23 | +1.6% | $962.7MEst: $885.8M | +8.7% |  10-K |
| Oct 30, 2025 | Q3 2025 | $1.62Est: $1.57 | +3.2% | $961.1MEst: $952.1M | +0.9% | 10-Q |
| Jul 31, 2025 | Q2 2025 | $1.66Est: $1.58 | +5.1% | $966.0MEst: $952.6M | +1.4% | 10-Q |
| May 1, 2025 | Q1 2025 | $1.20Est: $1.15 | +4.3% | $887.3MEst: $898.6M | -1.3% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $1.52Est: $1.26 | +20.6% | $848.1MEst: $852.3M | -0.5% | 10-K |
| Oct 24, 2024 | Q3 2024 | $1.49Est: $1.42 | +4.9% | $909.3MEst: $922.3M | -1.4% | 10-Q |
| Jul 25, 2024 | Q2 2024 | $1.37Est: $1.36 | +0.7% | $910.1MEst: $933.2M | -2.5% | 10-Q |
| Apr 25, 2024 | Q1 2024 | $1.26Est: $1.15 | +9.6% | $915.4MEst: $890.3M | +2.8% | 10-Q |
| Feb 8, 2024 | Q4 2023 | $1.21Est: $1.12 | +8.0% | $838.5MEst: $842.5M | -0.5% | 10-K |
| Oct 25, 2023 | Q3 2023 | $1.39Est: $1.27 | +9.4% | $893.0MEst: $908.5M | -1.7% | 10-Q |
| Jul 27, 2023 | Q2 2023 | $1.23Est: $1.14 | +7.9% | $895.9MEst: $898.8M | -0.3% | — |
| Apr 27, 2023 | Q1 2023 | $0.95Est: $0.90 | +5.6% | $860.1MEst: $829.9M | +3.6% | — |